Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy [Clinical Sciences]

Conclusions—Low-dose alteplase may improve outcomes in thrombolysis-treated acute ischemic stroke patients on prior APT, but this requires further evaluation in a randomized controlled trial.Clinical Trial Registration—URL: http://www.clinicaltrials.gov. Unique identifier: NCT01422616.

Source: Stroke - June 26, 2017 Category: Neurology Authors: Thompson G. Robinson, Xia Wang, Hisatomi Arima, Philip M. Bath, Laurent Billot, Joseph P. Broderick, Andrew M. Demchuk, Geoffery A. Donnan, Jong S. Kim, Pablo M. Lavados, Tsong-Hai Lee, Richard I. Lindley, Sheila C. O. Martins, Veronica V. Olavarria, Jeya Tags: Intracranial Hemorrhage, Ischemic Stroke Original Contributions Source Type: research